We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Systematic review highlights motor function and other outcomes in adults with spinal muscular atrophy treated with risdiplam, suggesting meaningful benefits.
To review real-world (RW) outcomes in adults with SMA treated with risdiplam.
No takes yet. Share an insight, caveat, or question.
Guittari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: